IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients

✍ Scribed by María P. Roberti, Yamila S. Rocca, Mora Amat, María B. Pampena, José Loza, Federico Coló, Verónica Fabiano, Carlos M. Loza, Juan M. Arriaga, Michele Bianchini, María M. Barrio, Alicia I. Bravo, Enzo Domenichini, Reinaldo Chacón, José Mordoh, et al

• Book ID: 118796776
• Publisher: Springer US
• Year: 2012
• Tongue: English
• Weight: 756 KB
• Volume: 136
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-012-2287-y